Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Finasteride helps female-pattern hair loss.

The inhibitor affects androgen metabolism but not ovarian function.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Eucalyptus and Tween 80 most effectively increase cetirizine skin absorption.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Microneedles help treat hair loss by improving hair surroundings and promoting growth.

Euph E and Euri A from Euphorbia neriifolia help control inflammation and immune response in cells.

Topical estrogen treatments did not change hair growth in certain mouse strains, questioning previous findings on their role in hair growth control.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Curcumin applied to the skin can start hair growth in mice.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

A man developed skin issues from cancer medication, which improved with specific treatments.

Two new compounds were found to effectively reduce hair growth in mice.

Erlotinib can cause excessive eyelash growth.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.